Equity Overview
Price & Market Data
Price: $0.0₅1
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $124,111
Volume: 0
Details
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.